In HCC, the expression of NDRG2 is downregulated, which is consistent with our findings, and down-regulation of NDRG2 expression can significantly increase tumor angiogenesis via the VEGFA pathway [59]. The gene discussed is VEGFA; the disease is hepatocellular carcinoma.